Already widely used in countries with better economic relations to Havana, the drug (which is far cheaper and less toxic than chemotherapy) seems capable of extending the lives of critical patients by four to six months, buying them some much needed time. The excitement over Cimavax is just the beginning of Cubas potential in the biomedical field. Thanks to its long isolation from major medical markets and intense poverty, the island nation has long prioritized innovation and technology. They currently hold about 1,200 international medical patents and market their goods to over 50 nationsCuba is especially well known for itstop-notch...
http://magazine.good.is/articles/cuba-medicine-doctors-normalization-cimavax